Category Archives: Health: Addiction

Addiction one of the Largest growing Problem’s in the world today. This Press Release Service will bring you the newest services and research available.

Ideal Option Opens Addiction Medicine Clinic in Bentonville


Ideal Option, a national leader in evidence-based outpatient treatment for addiction to fentanyl, heroin, methamphetamine, alcohol and polysubstance, is now welcoming new patients in Bentonville. The new clinic, located at 907 SE Village Loop, Suite 3, will provide primarily buprenorphine-based medication-assisted treatment with an onsite addiction medicine specialist.

While opioid prescribing and heroin use is on the decrease, overdose deaths continue to increase in Arkansas, largely due to the prevalence of fentanyl in the illicit drug supply.

According to data from the county coroners, the number of fatal drug overdoses in Benton and Washington counties nearly doubled in the past three years — from 42 in 2020 to 74 in 2022.

Fentanyl is regularly mixed with other illicit drugs to make them more addictive, often without the user knowing. Polysubstance use disorder is therefore now the most common diagnosis at Ideal Option. In 2022, over half of all Arkansas patients tested positive for more than one substance at enrollment, and 24% tested positive for three or more substances.

The report does offer hope however, by showing how effective medication-assisted treatment is for reducing substance use. For patients who remained in treatment with Ideal Option during 2022, lab testing shows:

  • 94% less fentanyl use
  • 87% less total opioid use
  • 96% less heroin use
  • 77% less methamphetamine use
  • 90% less cocaine use

The new clinic in Bentonville is Ideal Option’s ninth location in Arkansas and is opening at a time of desperate need for expanded access to evidence-based treatment from experienced providers. Ideal Option has been specializing in addiction medicine using buprenorphine-based medications such as Suboxone® for 11 years and currently operates 89 clinics in 11 states.

“In 2022, Ideal Option helped more than 1,000 patients living in Arkansas get started in recovery,” said Aaron Bunch, community outreach coordinator for Ideal Option. “I am excited to expand our life-saving treatment services to Bentonville and look forward to building relationships within this wonderful community.”

The new Ideal Option clinic in Bentonville is open Monday – Thursday, 7:30 a.m. – 6 p.m. and is located at 907 SE Village Loop, Suite 3, Bentonville, AR 72712.

Most forms of insurance are accepted, including Medicare and Medicaid, and patients can typically get started on treatment for fentanyl, heroin, alcohol or other substances within 1-3 business days.

Patients can make an appointment by calling 1.877.522.1275 or visiting http://www.idealoption.com.

About Ideal Option

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 65,000 patients through a network of 89 office-based medication-assisted treatment (MAT) clinics across 11 states. With a mission to serve under-served communities, Ideal Option accepts most forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Share article on social media or email:

New Book of Daily Devotionals Hopes to Offer Healing for Those Struggling with Addiction


News Image

“Recovery is a lifelong journey, and no one should have to walk it alone,” said Meads. “Through this devotional, I desire to show readers struggling with addiction that they will find strength, encouragement, and the support needed to keep moving forward.”

Addiction is argued to be a debilitating struggle that affects millions of people worldwide. In some cases, individuals who struggle with addiction may turn to faith for strength and guidance, but finding the right resources may be challenging. Hoping to offer support, author Wayne Meads Jr. is excited to release his new book, “180 Degrees in 180 Days.”

Meads offers a daily devotional that encourages readers to discover freedom from active addiction or merely help redefine what they may need to live a fulfilling life. The timeline in the book attempts to coincide with the readers’ physical and mental pain and emotional turmoil from the first days of recovery until the 180th day. Additionally, it touches on the pain and shame one may feel at the beginning of treatment and progresses to the success of a new beginning.

“Addiction is a complex issue, as it can be easy to feel alone and overwhelmed in the struggle,” said Meads. “As someone who has battled it myself, I wanted to create a resource that would help others find hope and healing through faith.”

Meads hopes by committing 15 minutes a day to read and incorporate his suggestion, the reader’s recovery may be built on solid ground that emphasizes the importance of a relationship with God along with the 12-step program.

“Recovery is a lifelong journey, and no one should have to walk it alone,” said Meads. “Through this devotional, I desire to show readers struggling with addiction that they will find strength, encouragement, and the support needed to keep moving forward. God has a plan and a purpose for everyone’s life outside of addiction that they could never imagine.”

“180 Degrees in 180 Days”

By Taylor Moralez

ISBN: 9781665737913 (softcover); 9781665737906 (electronic)

Available at Archway Publishing, Amazon and Barnes & Noble

About the author

Wayne Meads Jr. continues to preach the message of Jesus Christ as a Salvationist and inspiring those fighting addiction to embrace all that the Bible along with a 12-step program has to offer. For 25 years Wayne has had to battle his own addictions and understands the vicious cycle that seems to never end. After years of sobriety, he still believes that the incorporation of a Christ centered life along with the fellowship of a 12-step program maximizes one’s efforts to fulfill a life of freedom from active addiction. Today he continues to preach the gospel as well as attend meetings and shares his newfound life with his wife Claudia and two kids Micah and Lilah. To learn more, please visit https://www.archwaypublishing.com/en/bookstore/bookdetails/847703-180-degrees-in-180-days.

General Inquiries:            

LAVIDGE – Phoenix                        

Taylor Moralez

Tmoralez@lavidge.com

Share article on social media or email:

Northeast Delta HSA launches campaign to educate, create awareness about Fentanyl misuse


Northeast Delta HSA launches campaign to educate, create awareness about Fentanyl misuse

Northeast Delta HSA launches campaign to educate, create awareness about Fentanyl misuse

“Fentanyl is addictive, and it’s everywhere. It’s not just in the big cities you hear about on the news; it’s here in our front and backyards.” – Dr. Monteic A. Sizer

Northeast Delta Human Services Authority (NEDHSA) announces the launch of its Fentanyl is Forever campaign, an initiative to increase awareness of fentanyl risks and its impact on communities and families.

NEDHSA Executive Director Dr. Monteic A. Sizer said this campaign was “created to bring attention to the opioid issue in our region and provide resources to individuals seeking treatment for themselves or a loved one. Additionally, this campaign was designed to share information and resources with behavioral health professionals, physicians, and policymakers.”

“No one agency or community can solve this complex problem alone,” Dr. Sizer said. “Opioid addiction will be successfully mitigated once we develop enough compassion for those addicted and get them the evidence-based treatment they need, work to reduce those negative social determinants that drive their addiction, and help the people addicted to opioids find something meaningfully to live for other than drugs.”

Fentanyl is a synthetic opioid that is up to 50 times stronger than heroin and 100 times stronger than morphine. It is a major contributor to fatal and nonfatal overdoses in the U.S. Even in small doses, it can be deadly. Over 150 people die daily from overdoses related to synthetic opioids like Fentanyl.

NEDHSA’S Opioid Use Disorder Prevention Manager Kara Jackson Etienne, LMSW, said, “the campaign’s website conveys the risk associated with opioid use and misuse. Any pill or powder substance obtained from an unlicensed provider could have fentanyl in it.”

“We directly tell viewers all it takes is seven grains (about the size of table salt) to die,” Etienne said. “Fentanyl gives no warning signs of an overdose. It has no smell or special color. It has been showing up in other drugs on the street and at parties. Whether it’s your first use or tenth, it can very easily become your last time.”

On the newly released website http://www.nedeltahsa.org/fentanyl-is-forever/, the prevention messages unfold through five diverse short stories that allow people to experience and understand the risks of Fentanyl to their friends, families, and communities. In addition to warning the public about the dangers of Fentanyl, viewers are then linked to local resources for more information and help. The campaign includes local television, radio, billboards, newspapers, and social media ads.

NEDHSA oversees the administration of the state’s Opioid Response Plan. This plan is tasked with decreasing the effects of the opioid epidemic in Northeast Louisiana through five pillars: surveillance, prevention, intervention, treatment, and recovery.

NEDHSA, through its Prevention and Wellness Department, provides the Opioid Misuse and Abuse Prevention Program (OMAPP), which is funded by the Louisiana State Opioid Response (LaSOR) Grant. Through OMAPP, NEDHSA staff provides Narcan training and distribution, safe medication storage and disposal products, grief counseling, nursing, and peer support services through its crisis mobile team. NEDHSA staff also provides evidence-based programs like LifeSkills and Generation Rx. These services are provided at no cost to all who reside in NEDHSA’s catchment area.

Dr. Sizer added: “Fentanyl is addictive, and it’s everywhere. It’s not just in the big cities you hear about on the news; it’s here in our front and backyards. We are continuing to take every opportunity to spread the word to prevent fentanyl-related overdose deaths. We also intend to do everything we can to help those addicted to opioids recover and thrive.”

Share article on social media or email:

Grand Opening Ribbon Cutting for American Treatment Network Outpatient Drug and Alcohol Treatment Facility at Crozer Health


American Treatment Network

We welcome this opportunity to help serve the people of Delaware County and work closely with Crozer Health, as they continue to support the behavioral health needs of the county.

On Tuesday, April 11th from 10:30am-12:00pm, American Treatment Network will host a Grand Opening Ribbon Cutting Ceremony to formally open its state-of-the-art integrated SUD treatment model on the campus of Crozer-Chester Medical Center, at Suite 207 of Medical Office Building 1 in Upland, PA. Senator John Kane will be in attendance of the grand opening for the new outpatient drug and alcohol center that will provide much-needed services to county residents living with substance abuse disorders and mental health conditions.

In October of 2022, Crozer Health named American Treatment Network as its preferred provider for outpatient drug and alcohol services in Delaware County, PA. Located within the Chester-Crozer medical campus at MOB 1, Suite 207, American Treatment Network will work in conjunction with Crozer Health System by offering outpatient drug and alcohol services as well as acting as a 24/7 Assessment Center for Delaware County. American Treatment Network will act as the primary substance use treatment provider for all Crozer Health emergency rooms and physicians network. By partnering with American Treatment Network, Crozer will be equipped with all the tools needed to treat substance abuse and mental health issues within the community.

Matthew Sullivan, ATN’s co-founder and CEO, stated, “We welcome this opportunity to help serve the people of Delaware County and work closely with Crozer Health, as they continue to support the behavioral health needs of the county.” He continued, “As the largest health system in the county, Crozer Health can continue to lead in the fight to help undo the damage caused by the opioid epidemic in the county.”

About American Treatment Network:

American Treatment Network is a value based, multi-state outpatient substance abuse provider with operations throughout Pennsylvania and Delaware. American Treatment Network was founded to disrupt the current fragmented outpatient addiction treatment landscape by promoting health equity to all who seek outpatient addiction care. For more information, visit http://www.americantreatmentnetwork.com

Share article on social media or email:

Ideal Option Opens Addiction Medicine Clinic in Russellville


Ideal Option, a national leader in evidence-based outpatient treatment for addiction to fentanyl, heroin, methamphetamine, alcohol and polysubstance, is now welcoming new patients in Russellville. The new clinic, located at 902 W Main St, will provide primarily buprenorphine-based medication-assisted treatment with an onsite addiction medicine specialist.

While opioid prescribing and heroin use is on the decrease, overdose deaths continue to increase in Arkansas, largely due to the prevalence of fentanyl in the illicit drug supply.

According to a press release published by the Pope County Sheriff’s Office in January of this year, authorities seized approximately 19,500 fentanyl pills at a traffic stop conducted within the city limits of Russellville.

“Agents believed at the time of the seizure there was no intent to traffic this drug to other states, but that it would be sold locally in the Pope County area,” the release stated.

Fentanyl is regularly mixed with other illicit drugs to make them more addictive, often without the user knowing. Polysubstance use disorder is therefore now the most common diagnosis at Ideal Option. According to their Annual Patient Outcomes Report for Arkansas, in 2022, over half of all Ideal Option patients tested positive for more than one substance at enrollment, and 24% tested positive for three or more substances.

The report does offer hope however, by showing how effective medication-assisted treatment is for reducing substance use. For patients who remained in treatment with Ideal Option during 2022, lab testing shows:

  • 94% less fentanyl use
  • 87% less total opioid use
  • 96% less heroin use
  • 77% less methamphetamine use
  • 90% less cocaine use

The new clinic in Russellville is Ideal Option’s seventh location in Arkansas and is opening at a time of desperate need for expanded access to evidence-based treatment from experienced providers. Ideal Option has been specializing in addiction medicine using buprenorphine-based medications such as Suboxone® for 11 years and currently operates 88 clinics in 11 states.

“According to the Pope County Opioid Dashboard published by Arkansas Take Back, there are only three medication-assisted treatment providers located here,” said Aaron Bunch, community outreach coordinator for Ideal Option. “I am excited for the opportunity to form partnerships in Russellville and make a positive impact by bringing in additional resources to treat the residents of this wonderful community.”

The new Ideal Option clinic in Russellville is open Monday – Thursday, 7:30 a.m. – 6 p.m. and is located at 902 W Main St, Russellville, AR 72801.

Most forms of insurance are accepted, including Medicare and Medicaid, and patients can typically get started on treatment for fentanyl, heroin, alcohol or other substances within 1-3 business days.

Patients can make an appointment by calling 1.877.522.1275 or visiting http://www.idealoption.com.

About Ideal Option

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 65,000 patients through a network of 88 office-based medication-assisted treatment (MAT) clinics across 11 states. With a mission to serve under-served communities, Ideal Option accepts most forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Share article on social media or email:

New Scientific Evidence Emerges on How Individuals Transition From Recreational to Compulsive Use of Drugs


While substance use disorder (SUD) remains a clinically and socially devastating condition in the U.S. and worldwide, the phenomenon of how individuals transition from recreational to compulsive drug use is yet to be fully understood.

Researchers at the Icahn School of Medicine at Mount Sinai have opened the door to a promising new realm of discovery with the identification of a molecule and a previously unsuspected signaling pathway that appear to be pivotal to the pathophysiology of drug addiction. The molecule is known as Retinoid X Receptor Alpha (RXRα) in the nucleus accumbens, a key brain region for addiction, which appears to dictate in part the sensitivity of individuals to the initially rewarding properties of drug use. The team’s findings were reported in the journal Neuron.

Specifically, the nucleus accumbens is a region of the brain’s reward circuitry that integrates midbrain inputs of dopamine — a neurotransmitter that affects many aspects of behavior, including how we experience pleasure – to shape reward- and motivation-related behaviors. Within this construct, researchers in the Nash Family Department of Neuroscience and the Friedman Brain Institute at Icahn Mount Sinai learned that RXRα positively correlated with addiction-relevant behavioral features in laboratory rodents — a finding that makes the molecule a strong mechanistic candidate to link individual vulnerability to cocaine addiction. Fundamental to the study was RNA sequencing on six regions of the rodent’s brain reward circuitry after cocaine self-administration, withdrawal, and relapse in mice.

The discovery not only paves the way for future research on the novel signaling pathway, but on preventive strategies for drug addiction targeting RXRα. The Mount Sinai team showed that inhibition of the molecule using a systemically administered RXRα antagonist reduced cocaine-induced associative learning with tolerable side effects. Scientists were particularly intrigued and encouraged by the fact that a single molecule could have such a profound effect on modulating complex behaviors related to drug addiction. It further highlighted for them the effectiveness of bioinformatically harnessing large-scale datasets as part of the effort to unravel novel answers to brain maladaptations in an unbiased manner.

Previous studies have linked RXRα signaling to other neuropsychiatric pathologies — including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and diabetes — and Mount Sinai researchers believe that their latest findings could lead to future studies of RXRα involvement in psychiatric disease states like these. Over the short term, they plan to apply their groundbreaking research to opioid drugs, whose rampant spread and abuse resulted in more than 564,000 deaths in the U.S. from overdose in the period 1999 to 2020, and for which early evidence suggests a similar action of RXRα.

Who: Arthur Godino, neuroscience graduate student, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, and Eric J. Nestler, MD, PhD, the Nash Family Professor of Neuroscience, Director of the Friedman Brain Institute, and Dean for Academic Affairs at Icahn Mount Sinai, and Chief Scientific Officer of the Mount Sinai Health System.

Funding: The study was supported by the Boehringer Ingelheim Fonds (PhD Fellowship to A.G.) and the National Institute on Drug Addiction (P01DA047233 to E.J.N.).

Share article on social media or email:

Reframe Named to Fast Company’s List of the World’s Most Innovative Companies for 2023


“We’re so honored to make the list this year for most innovative companies and we continue to be motivated by the impact we’ve had so far on so many lives. It truly inspires us to see so many people in our community making positive changes.” – Vedant Pradeep, Cofounder & CEO of Reframe

Reframe has been named to Fast Company’s prestigious annual list of the https://www.fastcompany.com/most-innovative-companies/list for 2023.

This year’s list highlights the businesses at the forefront of their respective industries, paving the way for the innovations of tomorrow. These companies are setting the standard with some of the greatest accomplishments of the modern world. In addition to the World’s 50 Most Innovative Companies, 540 organizations are recognized across 54 sectors and regions.

“We’re so honored to make the list this year for most innovative companies and we continue to be motivated by the impact we’ve had so far on so many lives. It truly inspires us to see so many people in our community making positive changes and supporting others on the journey.” –Vedant Pradeep, Cofounder & CEO of Reframe.

The Reframe app has helped more than two million people over the past 18 months to cut back on or quit drinking alcohol. Unlike other programs, the app uses neuroscience to help people examine their relationship with alcohol, without the stigma that is usually associated with services to help people curb their drinking.

The team has created a robust program developed by trained psychologists, psychiatrists, and researchers from universities including Emory, Stanford, and Harvard. It brings together a personalized daily program, community support, progress tracking, tools to manage cravings, and one-on-one coaching all in one place. Within three months of using the app, 88-percent of users report a significant decrease in alcohol consumption. The overall goal is to give people the tools they need to reach their full potential.

Fast Company’s editors and writers sought out the companies making the biggest strides around the globe. They also judged nominations received through their application process.

The World’s Most Innovative Companies is Fast Company’s signature franchise and one of its most highly anticipated editorial efforts of the year. It provides a firsthand look at the inspiring and innovative efforts of companies across all sectors of the economy.

“What a strange and thrilling year it has been to honor this year’s Most Innovative Companies,” said Fast Company editor-in-chief Brendan Vaughan. “This year’s list compiles some of the most cutting-edge groundbreakers who are changing our world every single day, from legacy organizations like McDonald’s to upstarts like MrBeast and institutions such as NASA. Everyone on this list does something completely, uniquely different, yet, they all have one thing in common: innovation.”

Fast Company will host its third annual Most Innovative Companies Summit on April 19 and 20. The virtual summit celebrates the Most Innovative Companies in business, and provides an inside look at cutting-edge business trends and what it takes to innovate in 2023. Fast Company’s Most Innovative Companies issue (March/April 2023) is available online here and on newsstands beginning March 14. The hashtag is #FCMostInnovative.

ABOUT REFRAME: Reframe was founded by Vedant Pradeep & Ziyi Gao, both immigrants who met while studying engineering at Georgia Tech. They’ve raised more than $27 million from leading investors such as Goodwater Capital, Y Combinator, HOF Capital, and Atlanta Ventures. The app uses a neuroscience-based approach to help people cut back on or quit drinking alcohol, and discover the best version of themselves.

ABOUT FAST COMPANY

Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication Inc., and can be found online at http://www.fastcompany.com.

Share article on social media or email:

The Psychiatric Rehabilitation Association has teamed up with MISSION to offer new Psychiatric Rehabilitation courses online


News Image

“We are so excited PRA is disseminating this new training series and could not think of a better partner. The MISSION approach is to use evidence-based practices within a system of care that helps to support and sustain recovery.” – David Smelson, PsyD.

The Psychiatric Rehabilitation Association and the Psychiatric Rehabilitation Foundation (PRA/F) are dedicated to the growth and training of the recovery workforce while promoting wellness and recovery. The purpose of PRA/F is to provide information and resources to improve the practice of psychiatric rehabilitation.

“One of our primary goals is to refresh the course offerings available to the recovery workforce and provide the best resources to our members. The MISSION Model was at the top of our list, and it’s just the beginning of new resources we plan on offering soon.” – Dori Hutchinson, PhD, Psychiatric Rehabilitation Foundation Chair.

So, what is MISSION? Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking (MISSION) is an evidence-based intervention developed by David Smelson and his team at the University of Massachusettes Chan School of Medicine to consider the mental health, substance misuse, and other psychosocial needs of individuals with co-occurring mental health and substance use disorders (CODs). MISSION has been building its evidence base for the past 26 years and has recently been written about in a National institute of Health Spotlight as a novel whole health approach to recovery.

“We are so excited PRA is disseminating this new training series and could not think of a better partner. The MISSION approach is to use evidence-based practices within a system of care that helps to support and sustain recovery.” – David Smelson, PsyD.

The new online course consists of seven self-paced, asynchronous, e-learning modules explicitly developed for providers involved in treating individuals with co-occurring mental health and substance use disorders. Each of the seven modules is an interactive stand-alone course that includes video, knowledge checks, and a final exam. Module One provides an overview of the MISSION Model, and Modules 2-6 address the implementation of each of the five vital evidence-based components of the MISSION Model of Care. The final module, Module 7, integrates all the components of the MISSION Model within a case study.

The Psychiatric Rehabilitation Association (PRA) is a membership organization that advocates for Psychiatric Rehabilitation on the Federal and State level, certifying professionals with the CPRP and CFRP credentials and providing a local community for those in the workforce through state chapters and affiliates. The Academy for Psychiatric Rehabilitation and Recovery is the premiere source of live and online training and education for the psych rehab workforce. The Academy is the educational arm of the Psychiatric Rehabilitation Foundation (PRF), an IRS-recognized 501c3 nonprofit organization with evolving research, grants, and public outreach initiatives.

This MISSION Training Series was supported by the following grants: NIH/NIAAA R41DA044030-01A1 and R42 AA026751-2

All of the work was done at the University of Massachusetts Chan Medical School and licensed to Psychiatric Rehabilitation Association.

Share article on social media or email:

Ideal Option Partners with Snohomish County and Others to Host Take Back and Recovery Event


Ideal Option, a national leader in outpatient medication-assisted treatment for opioids, methamphetamine, alcohol and polysubstance, is partnering with Holman Recovery Center, Snohomish County Health Department, Marysville Police Department, EvergreenHealth Monroe, Providence, Catholic Community Services, A1 Lifeline, Washington 2-1-1, and The Hand Up Project to help people in Marysville get started in recovery.

According to the Medical Examiner’s Office Drug Overdose Dashboard, in Snohomish County alone, there were 162 overdose deaths involving opioids in 2022, with 141 of those involving fentanyl.

Ideal Option data support the effectiveness of medication-assisted treatment for opioid use disorder. Among patients who remained in treatment with Ideal Option during 2021, urine drug testing shows 98% less fentanyl use and 93% less total opioid use.

Recovery Starts Today! will take place on Friday, February 24, 10 a.m. – 2 p.m. at the Ideal Option clinic in Marysville located at 1617 Grove St. Attendees can surrender illicit substances and paraphernalia for safe disposal, learn about community resources, complete intake and, if desired, see a provider immediately to start medication-assisted treatment. For nearly all patients, costs are covered by Medicaid or private insurance.

This event is designed to empower those in the community who are struggling with the disease of addiction to come forward without fear of legal repercussions and begin their recovery with medication-assisted treatment.

For questions about this event, email Senior Marketing Manager Olivia Roe at oliviaroe@idealoption.net.

About Ideal Option

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 65,000 patients through a network of 84 office-based medication-assisted treatment (MAT) clinics across 11 states. With a mission to serve under-served communities, Ideal Option accepts all forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Share article on social media or email:

Drug Director Boyce Hamlet to Speak at Ideal Option Open House


Ideal Option, a national leader in outpatient medication-assisted treatment for opioids, methamphetamine, alcohol and polysubstance, will host an open house at their clinic in Springdale at 2112 W Huntsville Ave, Ste. B. The event will kick off with an opening address from newly appointed Arkansas Drug Director Boyce Hamlet.

During the height of the COVID-19 pandemic, substance use and overdose deaths skyrocketed across Arkansas. According to the AR Opioid Dashboard, in Washington County alone, overdose deaths increased by 79% from 2020 to 2021.

Ideal Option data from 2021 show 44% of patients in Arkansas tested positive for multiple substances at enrollment, most commonly opioids and methamphetamine.

On Wednesday, February 15, from 4 p.m. to 7 p.m., all members of the community are invited to attend the Open House at Ideal Option’s clinic in Springdale located at 2112 W Huntsville Ave, Ste. B.

During the open house, attendees can enjoy refreshments and learn more about the services provided by Ideal Option, tour the facility, meet expert staff and pick up materials.

For questions about this event, email Senior Marketing Manager Olivia Roe at oliviaroe@idealoption.net.

About Ideal Option

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 65,000 patients through a network of over 80 office-based medication-assisted treatment (MAT) clinics across 11 states. With a mission to serve under-served communities, Ideal Option accepts all forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Share article on social media or email: